Consolidated Statements of Income (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Revenues
Revenues	$ 10,710	$ 11,818
Costs and operating expenses:
Selling, general and administrative expenses	2,119	2,277
Research and development expenses	346	364
Restructuring and other costs	112	2
Total costs and operating expenses	9,147	8,997
Operating income	1,563	2,821
Interest income	146	18
Interest expense	(300)	(136)
Other income/(expense)	(46)	(163)
Income before income taxes	1,363	2,540
Provision for income taxes	(46)	(301)
Equity in earnings/(losses) of unconsolidated entities	(25)	(19)
Net income	1,292	2,220
Less: net income/(losses) attributable to noncontrolling interests and redeemable noncontrolling interest	3	5
Net income	$ 1,289	$ 2,215
Earnings per share attributable to Thermo Fisher Scientific Inc.
Basic (in dollars per share)	$ 3.34	$ 5.66
Diluted (in dollars per share)	$ 3.32	$ 5.61
Weighted average shares
Basic (in shares)	386	392
Diluted (in shares)	388	395
Product revenues
Revenues
Revenues	$ 6,404	$ 8,017
Costs and operating expenses:
Cost of revenues	3,337	3,555
Service revenues
Revenues
Revenues	4,306	3,801
Costs and operating expenses:
Cost of revenues	$ 3,233	$ 2,799